New Results
High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households
View ORCID ProfileMatthieu Fritz, Béatrice Rosolen, View ORCID ProfileEmilie Krafft, View ORCID ProfilePierre Becquart, Eric Elguero, View ORCID ProfileOxana Vratskikh, View ORCID ProfileSolène Denolly, View ORCID ProfileBertrand Boson, View ORCID ProfileJessica Vanhomwegen, View ORCID ProfileMeriadeg Ar Gouilh, View ORCID ProfileAngeli Kodjo, Catherine Chirouze, View ORCID ProfileSerge Rosolen, View ORCID ProfileVincent Legros, View ORCID ProfileEric M. Leroy
doi: https://doi.org/10.1101/2020.09.22.307751
Matthieu Fritz
1Institut de Recherches et de Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - UM), Montpellier, France (
Béatrice Rosolen
2Service de maladies infectieuses et tropicales, CHRU hôpital Jean-Minjoz, Besançon, France
Emilie Krafft
3Université de Lyon, VetAgro Sup, Campus vétérinaire de Lyon, Marcy-l’Etoile, France
Pierre Becquart
1Institut de Recherches et de Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - UM), Montpellier, France (
Eric Elguero
1Institut de Recherches et de Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - UM), Montpellier, France (
Oxana Vratskikh
4Environment and Infectious Risk Unit, Laboratory for Urgent Response to Biological Threats, Institut Pasteur, Paris, France
Solène Denolly
5CIRI – Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, Lyon, France
Bertrand Boson
5CIRI – Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, Lyon, France
Jessica Vanhomwegen
4Environment and Infectious Risk Unit, Laboratory for Urgent Response to Biological Threats, Institut Pasteur, Paris, France
6The OIE Collaborating Centre for Detection and Identification in Humans of Emerging Animal Pathogens, Institut Pasteur, Paris, France
Meriadeg Ar Gouilh
7Groupe de Recherche sur l’Adaptation Microbienne (GRAM 2.0), Normandie Univ, UNICAEN, UNIROUEN, EA2656, Caen, France
8Laboratoire de Virologie, Centre Hospitalo-Universitaire, Caen, France
Angeli Kodjo
3Université de Lyon, VetAgro Sup, Campus vétérinaire de Lyon, Marcy-l’Etoile, France
Catherine Chirouze
2Service de maladies infectieuses et tropicales, CHRU hôpital Jean-Minjoz, Besançon, France
9UMR Chrono-Environnement - Université de Bourgogne Franche-Comté, Besançon, France
Serge Rosolen
10Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France
11Clinique Veterinaire Voltaire, Asnieres, France
Vincent Legros
3Université de Lyon, VetAgro Sup, Campus vétérinaire de Lyon, Marcy-l’Etoile, France
5CIRI – Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, Lyon, France
Eric M. Leroy
1Institut de Recherches et de Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - UM), Montpellier, France (
Abstract
In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.
Competing Interest Statement
The authors have declared no competing interest.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted September 22, 2020.
High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households
Matthieu Fritz, Béatrice Rosolen, Emilie Krafft, Pierre Becquart, Eric Elguero, Oxana Vratskikh, Solène Denolly, Bertrand Boson, Jessica Vanhomwegen, Meriadeg Ar Gouilh, Angeli Kodjo, Catherine Chirouze, Serge Rosolen, Vincent Legros, Eric M. Leroy
bioRxiv 2020.09.22.307751; doi: https://doi.org/10.1101/2020.09.22.307751
High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households
Matthieu Fritz, Béatrice Rosolen, Emilie Krafft, Pierre Becquart, Eric Elguero, Oxana Vratskikh, Solène Denolly, Bertrand Boson, Jessica Vanhomwegen, Meriadeg Ar Gouilh, Angeli Kodjo, Catherine Chirouze, Serge Rosolen, Vincent Legros, Eric M. Leroy
bioRxiv 2020.09.22.307751; doi: https://doi.org/10.1101/2020.09.22.307751
Subject Area
Subject Areas
- Biochemistry (13662)
- Bioengineering (10397)
- Bioinformatics (33075)
- Biophysics (17054)
- Cancer Biology (14121)
- Cell Biology (20043)
- Clinical Trials (138)
- Developmental Biology (10832)
- Ecology (15966)
- Epidemiology (2067)
- Evolutionary Biology (20299)
- Genetics (13373)
- Genomics (18599)
- Immunology (13705)
- Microbiology (32064)
- Molecular Biology (13354)
- Neuroscience (69861)
- Paleontology (523)
- Pathology (2178)
- Pharmacology and Toxicology (3729)
- Physiology (5845)
- Plant Biology (11991)
- Synthetic Biology (3358)
- Systems Biology (8146)
- Zoology (1840)